Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14129 | 29572095 | J Hepatol | A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. | 2018 | Details |
| A14130 | 29571977 | Diabetes Metab Syndr | Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. | 2018 | Details |
| A14131 | 29571924 | J Hepatol | High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. | 2018 | Details |
| A14133 | 29570139 | J Pediatr Gastroenterol Nutr | Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States. | 2018 | Details |
| A14141 | 29566909 | Best Pract Res Clin Gastroenterol | NAFLD, Helicobacter species and the intestinal microbiome. | 2017 | Details |
| A14143 | 29565507 | Eur Rev Med Pharmacol Sci | Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men. | 2018 | Details |
| A14144 | 29565153 | Nutr Hosp | Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents. | 2018 | Details |
| A14149 | 29563854 | Mediators Inflamm | Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14153 | 29561981 | Arq Gastroenterol | MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY. | 2018 | Details |
| A14156 | 29560693 | Acta Gastroenterol Belg | Apoptosis and Disease Severity is Associated with Insulin Resistance in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14159 | 29558460 | Int J Mol Sci | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. | 2018 | Details |
| A14172 | 29552625 | Cell Mol Gastroenterol Hepatol | Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). | 2017 | Details |
| A14176 | 29550812 | Cell Physiol Biochem | Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14177 | 29550470 | Biochem Biophys Res Commun | PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway. | 2018 | Details |
| A14181 | 29547708 | Atherosclerosis | Resolution of fatty liver and weight loss: Independent associations with changes in serum lipids and apolipoproteins. | 2018 | Details |
| A14183 | 29547047 | Endocr Pract | PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES. | 2018 | Details |
| A14190 | 29538359 | Pediatr Res | Gut microbiota in adolescents and the association with fatty liver: the EPOCH study. | 2018 | Details |
| A14195 | 29534506 | Nutrients | Saccharin Increases Fasting Blood Glucose but Not Liver Insulin Resistance in Comparison to a High Fructose-Fed Rat Model. | 2018 | Details |
| A14201 | 29527789 | Diabetes Obes Metab | Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14207 | 29526751 | Biochem Biophys Res Commun | Enoyl coenzyme A hydratase 1 protects against high-fat-diet-induced hepatic steatosis and insulin resistance. | 2018 | Details |
| A14218 | 29519663 | Surg Obes Relat Dis | Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? | 2017 | Details |
| A14225 | 29516226 | Eur J Nutr | Chronic fructose intake does not induce liver steatosis and inflammation in female Sprague-Dawley rats, but causes hypertriglyceridemia related to decreased VLDL receptor expression. | 2018 | Details |
| A14229 | 29514661 | J Transl Med | Physiological and molecular effects of interleukin-18 administration on the mouse kidney. | 2018 | Details |
| A14230 | 29514047 | Biochim Biophys Acta Mol Basis Dis | Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome. | 2018 | Details |
| A14234 | 29512720 | Mol Med Rep | Alogliptin alleviates hepatic steatosis in a mouse model of nonalcoholic fatty liver disease by promoting CPT1a expression via Thr172 phosphorylation of AMPKα in the liver. | 2018 | Details |
| A14235 | 29511882 | Curr Atheroscler Rep | Cardiometabolic Effects of Anti-obesity Pharmacotherapy. | 2018 | Details |
| A14236 | 29511669 | Biomed Res Int | Ethanol Extract from Ulva prolifera Prevents High-Fat Diet-Induced Insulin Resistance, Oxidative Stress, and Inflammation Response in Mice. | 2018 | Details |
| A14238 | 29510489 | Int J Mol Sci | Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. | 2018 | Details |
| A14240 | 29509436 | Am J Physiol Endocrinol Metab | Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. | 2018 | Details |
| A14242 | 29508519 | Mol Nutr Food Res | Caffeic Acid Phenethyl Ester Improves Metabolic Syndrome by Activating PPAR-γ and Inducing Adipose Tissue Remodeling in Diet-Induced Obese Mice. | 2018 | Details |
| A14243 | 29507903 | Hepatol Commun | Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease. | 2018 | Details |
| A14247 | 29507217 | Proc Natl Acad Sci U S A | High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. | 2018 | Details |
| A14248 | 29507043 | J Endocrinol | Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver. | 2018 | Details |
| A14251 | 29505553 | J Clin Gastroenterol | Prediction of Liver Steatosis Applying a New Score in Subjects from the Brazilian Longitudinal Study of Adult Health. | 2020 | Details |
| A14253 | 29504312 | J Zhejiang Univ Sci B | Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. | 2018 | Details |
| A14254 | 29503789 | Curr Hepatol Rep | Managing the Burden of Non-NASH NAFLD. | 2017 | Details |
| A14260 | 29498345 | Br J Nutr | 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat-high-fructose diet. | 2018 | Details |
| A14261 | 29497783 | Diabetologia | Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. | 2018 | Details |
| A14270 | 29491146 | J Biol Chem | Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease. | 2018 | Details |
| A14277 | 29487137 | Genetics | Seven-Up Is a Novel Regulator of Insulin Signaling. | 2018 | Details |
| A14280 | 29485130 | Am J Gastroenterol | The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth. | 2018 | Details |
| A14281 | 29484808 | Diabetes Obes Metab | Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. | 2018 | Details |
| A14285 | 29483369 | Biosci Rep | Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring. | 2018 | Details |
| A14289 | 29481986 | J Nutr Biochem | Replacement of soybean oil by fish oil increases cytosolic lipases activities in liver and adipose tissue from rats fed a high-carbohydrate diets. | 2018 | Details |
| A14295 | 29477657 | Eur J Pharmacol | Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway. | 2018 | Details |
| A14306 | 29471595 | Diabetes Metab Res Rev | Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease. | 2018 | Details |
| A14312 | 29470286 | J Pediatr Gastroenterol Nutr | Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14317 | 29469051 | Ann Hepatol | Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse. | 2018 | Details |
| A14323 | 29466466 | PLoS One | Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. | 2018 | Details |
| A14340 | 29456698 | Exp Ther Med | Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14344 | 29454969 | Biochem Biophys Res Commun | JIP3 knockout protects mice against high fat diet-induced liver injury. | 2018 | Details |
| A14345 | 29454967 | Biochem Biophys Res Commun | SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. | 2018 | Details |
| A14358 | 29450137 | Biochim Open | Liver and Metformin: Lessons of a fructose diet in mice. | 2017 | Details |
| A14371 | 29441342 | Can J Gastroenterol Hepatol | Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre. | 2017 | Details |
| A14374 | 29439143 | Biosci Rep | Anarchy in the UPR: A Ca2+-insensitive PKC inhibits SERCA activity to promote ER stress. | 2018 | Details |
| A14376 | 29438686 | J Pediatr (Rio J) | Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents. | 2018 | Details |
| A14390 | 29431403 | Am Fam Physician | Mildly Elevated Liver Transaminase Levels: Causes and Evaluation. | 2017 | Details |
| A14393 | 29429367 | Arch Physiol Biochem | Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation. | 2018 | Details |
| A14400 | 29427492 | Liver Int | Future therapy for non-alcoholic fatty liver disease. | 2018 | Details |
| A14407 | 29425212 | PLoS One | Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI. | 2018 | Details |
| A14408 | 29424123 | J Gastroenterol Hepatol | Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. | 2018 | Details |
| A14409 | 29421523 | Transl Res | Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet. | 2018 | Details |
| A14411 | 29420066 | Am J Physiol Gastrointest Liver Physiol | CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. | 2018 | Details |
| A14413 | 29419350 | Ultrastruct Pathol | Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet. | 2018 | Details |
| A14420 | 29414781 | J Biol Chem | Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway. | 2018 | Details |
| A14422 | 29414249 | Annu Rev Pathol | Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14426 | 29411334 | J Cell Commun Signal | Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes. | 2018 | Details |
| A14428 | 29411128 | Eur J Appl Physiol | Effects of sprint interval training on ectopic lipids and tissue-specific insulin sensitivity in men with non-alcoholic fatty liver disease. | 2018 | Details |
| A14432 | 29409538 | BMC Res Notes | Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis. | 2018 | Details |
| A14435 | 29408694 | J Hepatol | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. | 2018 | Details |
| A14444 | 29404514 | Hepatol Commun | Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A14450 | 29404483 | Hepatol Commun | Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease. | 2017 | Details |
| A14453 | 29404440 | Hepatol Commun | Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. | 2017 | Details |
| A14467 | 29399273 | World J Hepatol | Role of inflammatory response in liver diseases: Therapeutic strategies. | 2018 | Details |
| A14471 | 29398414 | Dig Liver Dis | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. | 2017 | Details |
| A14474 | 29396908 | Mol Nutr Food Res | Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas. | 2018 | Details |
| A14482 | 29391015 | Environ Health | Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003-2010. | 2018 | Details |
| A14494 | 29382663 | Diabetes | Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. | 2018 | Details |
| A14495 | 29381809 | Hepatology | Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice. | 2018 | Details |
| A14496 | 29381754 | PLoS One | Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection. | 2018 | Details |
| A14508 | 29377201 | Ann N Y Acad Sci | Cardiometabolic risk in obese children. | 2018 | Details |
| A14510 | 29376471 | Adipocyte | Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization. | 2018 | Details |
| A14519 | 29371918 | Oncotarget | Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis. | 2017 | Details |
| A14534 | 29364302 | Food Funct | Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. | 2018 | Details |
| A14537 | 29363914 | Pol J Pathol | Expression of resistin in the liver of patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14540 | 29362454 | Sci Rep | Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. | 2018 | Details |
| A14542 | 29361464 | Cell Syst | Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14552 | 29357809 | Cardiovasc Hematol Agents Med Chem | Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14559 | 29354946 | Zhongguo Zhen Jiu | [Mechanisms of acupuncture for non-alcoholic fatty liver disease: researches progress and prospects]. | 2018 | Details |
| A14570 | 29349944 | J Korean Med Sci | Investigation of Clinical and Pathological Relationships between Adult- and Pediatric-type NASH in Korean Children. | 2018 | Details |
| A14582 | 29341349 | Pathol Int | Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease. | 2018 | Details |
| A14583 | 29341046 | Horm Metab Res | Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children. | 2018 | Details |
| A14585 | 29338271 | Rev Esp Enferm Dig | Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A14604 | 29327118 | Sleep Breath | Effect of CPAP therapy on liver disease in patients with OSA: a review. | 2018 | Details |
| A14605 | 29327078 | Cell Mol Life Sci | The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? | 2018 | Details |
| A14609 | 29325294 | Zhonghua Gan Zang Bing Za Zhi | [Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice]. | 2017 | Details |
| A14620 | 29321172 | Diabetes | Modest Decreases in Endogenous All-trans-Retinoic Acid Produced by a Mouse Rdh10 Heterozygote Provoke Major Abnormalities in Adipogenesis and Lipid Metabolism. | 2018 | Details |
| A14622 | 29319180 | J Cell Physiol | WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. | 2018 | Details |
| A14635 | 29314568 | Liver Int | Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children. | 2018 | Details |
| A14642 | 29311481 | Biol Pharm Bull | A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation. | 2018 | Details |